A rational selection of drug targets needs deeper insights into general regulation mechanisms

Area of Science:

• Oncology
• Molecular Biology
• Pharmacology

Background:

• Despite advances in chemotherapy, cancer mortality rates remain high, underscoring the need for effective prevention and treatment strategies.
• Chemoprevention and chemotherapy are recognized as complementary approaches to combat human cancers.
• Current understanding of how complex cellular regulatory networks respond to small molecules is limited.

Purpose of the Study:

• To highlight the limitations in current drug discovery and development processes.
• To emphasize the need for a deeper understanding of fundamental cellular mechanisms.
• To advocate for a more rational approach to identifying molecular targets and designing anti-cancer drugs.

Main Methods:

• This study is a review and conceptual analysis of current challenges in cancer drug discovery.
• It synthesizes existing knowledge on cellular regulatory networks and drug mechanisms of action.
• It discusses the implications of limited mechanistic understanding for rational drug design.

Main Results:

• The empirical nature of current drug design is a significant barrier to developing more effective cancer therapies.
• Limited knowledge of cellular network behavior in response to drugs hinders the identification of optimal molecular targets.
• A lack of fundamental insights into cellular functions impedes a rational approach to drug discovery.

Conclusions:

• Further research into the fundamental mechanisms of cellular functions is essential for advancing cancer drug discovery.
• A comprehensive understanding of cellular regulatory networks is required to transition from empirical to rational drug design.
• Integrating chemoprevention and chemotherapy, guided by a deeper mechanistic understanding, holds promise for reducing cancer mortality.